HSTM
Neutral signalScored 2026-10-24 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
HealthStream, Inc.
- Nom
- HealthStream, Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Healthcare Information Services
- Bourse
- NASDAQ
- Capitalisation
- $1.1B
- Employés
- 1,150
- PDG
- Robert A. Frist Jr.
- Site web
- https://www.healthstream.com
- Marché
- AMWLCCLDDHEVHHCATHCTI
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 12 000 titres (~420 000,00 $ US)
- Insiders
- REBROVICK LINDA
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$420,000
Avg sell (VWAP, 90d window) $35.00 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-10-23
- Last synced
-
2026-10-26 22:35:44
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-23 | REBROVICK LINDA | Sell · S | 12,000 | $35.00 | $420,000 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2018-06-07 | Greg Gianforte | Sale (Full) | $50,001 - $100,000 |
Signal
Neutral signalScored 2026-10-24 Drivers: fundamentals. Moteurs : fondamentaux.
HSTM presents a mixed picture: while long-term profitability trends and cash flow generation are solid, the current ratio below 1.0 signals short-term liquidity stress and the RSI at ~80 points to a technically…
The first sentence of the analysis written for HSTM on 2026-10-24 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Unavailable or mixed. No stored price series
- Financial indicators Pulls against a bullish reading. Current ratio 0.96 · operating margin 6.7%
Recent news
- 2026-10-26 HealthStream to Host Third Quarter 2026 Earnings Conference Call NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its third quarter 2026 financial results on Tuesday, November 3, 2026. The Company''s financial results for the third quarter 2026, ended Sept. 30, 2026, will be released after the routine time for the close of the market on Monday, November 2, 2026. HealthStream''s third.
- 2026-10-18 Weave Communications (NYSE:WEAV) versus HealthStream (NASDAQ:HSTM) Financial Contrast HealthStream (NASDAQ: HSTM - Get Free Report) and Weave Communications (NYSE: WEAV - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider and Institutional Ownership 69.6% of HealthStream shares
- 2026-10-05 HealthStream (NASDAQ:HSTM) Reaches New 1-Year High – Should You Buy? Shares of HealthStream, Inc. (NASDAQ: HSTM - Get Free Report) reached a new 52-week high during trading on Monday. The company traded as high as $31.37 and last traded at $31.4540, with a volume of 6598 shares trading hands. The stock had previously closed at $30.36. Analyst Ratings Changes HSTM has been the subject of several
- 2026-09-17 Robert Frist, Jr. Sells 144,068 Shares of HealthStream (NASDAQ:HSTM) Stock HealthStream, Inc. (NASDAQ: HSTM - Get Free Report) CEO Robert Frist, Jr. sold 144,068 shares of the company''s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the transaction, the chief executive officer directly owned 3,907,038 shares of the company''s
- 2026-09-15 HealthStream Completes $40 Million Private Placement of Its Common Stock NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM) (the “Company”), a leading healthcare technology platform company for clinical workforce solutions, today announced the completion of a private placement transaction through which WJRJJ Ventures, LLC (“WJRJJ”) acquired a total of 1.5 million shares of the Company''s common stock. In this transaction, the Company issued 1,355,932 shares of common stock to WJRJJ for approximately $40 million in cash at a purchase price of $29.50.
- 2026-09-14 HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP) NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today defined the Enterprise Clinical Workforce Platform (ECWP), establishing a new enterprise category for healthcare built on a single, verified record for every clinician. For decades, health systems have standardized on two enterprise systems: the electronic health record (EHR) for the clinical record and enterprise resource planning (ERP) for fi.
- 2026-09-08 Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH) HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Earnings and Valuation This table compares HealthStream and
- 2026-08-11 Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce INDIANAPOLIS--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce.
- 2026-08-04 HealthStream, Inc. (HSTM) Q2 2026 Earnings Call Transcript HealthStream, Inc. (HSTM) Q2 2026 Earnings Call Transcript
- 2026-08-04 HealthStream Q2 Earnings Call Highlights HealthStream NASDAQ: HSTM reported record second-quarter revenue and adjusted EBITDA for 2026, citing growth in core subscription products, contributions from recent acquisitions and a one-time revenue catch-up tied to customer cost savings. The healthcare workforce technology company also raised its full-year revenue and adjusted EBITDA outlook while modestly lowering its net-income guidance as it increases investments in growth initiatives.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 64.7% | 66.4% | 65.9% | 65.8% | 64.5% | |
| Ebit Margin | 7.6% | 8.5% | 6.6% | 5.8% | 3.0% | |
| Ebitda Margin | 21.9% | 22.6% | 21.4% | 20.1% | 17.4% | |
| Operating Profit Margin | 6.7% | 7.3% | 5.7% | 4.7% | 3.1% | |
| Pretax Profit Margin | 7.6% | 8.5% | 6.6% | 5.8% | 3.0% | |
| Continuous Operations Profit Margin | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | |
| Net Profit Margin | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | |
| Bottom Line Profit Margin | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | |
| Current Ratio | 0.964 | 1.324 | 1.100 | 0.976 | 1.065 | |
| Quick Ratio | 0.964 | 1.324 | 1.100 | 0.976 | 1.065 | |
| Solvency Ratio | 0.372 | 0.405 | 0.354 | 0.306 | 0.289 | |
| Cash Ratio | 0.291 | 0.514 | 0.341 | 0.393 | 0.467 | |
| Price To Earnings Ratio | 37.820 | 48.182 | 54.060 | 63.692 | 138.737 | |
| Price To Earnings Growth Ratio | -4.992 | 1.506 | 1.917 | 0.605 | -2.442 | |
| Forward Price To Earnings Growth Ratio | -4.992 | 1.506 | 1.917 | 0.605 | -2.442 | |
| Price To Earnings Diluted Ratio | 37.820 | 48.182 | 54.060 | 63.692 | 146.444 | |
| Price To Earnings Diluted Growth Ratio | -4.992 | 1.506 | 1.917 | 0.546 | -2.478 | |
| Price To Book Ratio | 1.956 | 2.689 | 2.425 | 2.279 | 2.452 | |
| Price To Sales Ratio | 2.278 | 3.313 | 2.961 | 2.853 | 3.238 | |
| Price To Free Cash Flow Ratio | 11.613 | 32.735 | 13.378 | 15.405 | 21.331 | |
| Price To Operating Cash Flow Ratio | 10.937 | 16.758 | 12.918 | 14.873 | 19.612 | |
| Debt To Assets Ratio | 0.028 | 0.039 | 0.040 | 0.047 | 0.060 | |
| Debt To Equity Ratio | 0.041 | 0.056 | 0.059 | 0.070 | 0.086 | |
| Debt To Capital Ratio | 0.040 | 0.053 | 0.056 | 0.065 | 0.079 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.470 | 1.421 | 1.467 | 1.490 | 1.436 | |
| Working Capital Turnover Ratio | 18.462 | 11.837 | 61.925 | 145.846 | 288.765 | |
| Operating Cash Flow Ratio | 0.510 | 0.498 | 0.540 | 0.437 | 0.422 | |
| Operating Cash Flow Sales Ratio | 0.208 | 0.198 | 0.229 | 0.192 | 0.165 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.942 | 0.512 | 0.966 | 0.965 | 0.919 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 4.312 | 2.859 | 3.159 | 2.195 | 1.456 | |
| Capital Expenditure Coverage Ratio | 17.183 | 2.049 | 29.077 | 28.952 | 12.404 | |
| Dividend Paid And Capex Coverage Ratio | 8.540 | 1.828 | 12.166 | 28.952 | 12.336 | |
| Dividend Payout Ratio | 0.203 | 0.170 | 0.201 | 0.000 | 0.003 | |
| Enterprise Value Multiple | 10.061 | 14.035 | 13.531 | 13.798 | 18.247 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 64.7% | ▼-1.7% | ▼-0.8% |
| Ebit Margin | 7.6% | ▼-0.9% | ▲1.3% |
| Ebitda Margin | 21.9% | ▼-0.7% | ▲1.3% |
| Operating Profit Margin | 6.7% | ▼-0.6% | ▲1.2% |
| Pretax Profit Margin | 7.6% | ▼-0.9% | ▲1.3% |
| Continuous Operations Profit Margin | 6.0% | ▼-0.8% | ▲1.0% |
| Net Profit Margin | 6.0% | ▼-0.8% | ▲1.0% |
| Bottom Line Profit Margin | 6.0% | ▼-0.8% | ▲1.0% |
| Current Ratio | 0.964 | ▼-0.360 | ▼-0.122 |
| Quick Ratio | 0.964 | ▼-0.360 | ▼-0.122 |
| Solvency Ratio | 0.372 | ▼-0.033 | ▲0.027 |
| Cash Ratio | 0.291 | ▼-0.223 | ▼-0.110 |
| Price To Earnings Ratio | 37.820 | ▼-10.362 | ▼-30.678 |
| Price To Earnings Growth Ratio | -4.992 | ▼-6.498 | ▼-4.311 |
| Forward Price To Earnings Growth Ratio | -4.992 | ▼-6.498 | ▼-4.311 |
| Price To Earnings Diluted Ratio | 37.820 | ▼-10.362 | ▼-32.220 |
| Price To Earnings Diluted Growth Ratio | -4.992 | ▼-6.498 | ▼-4.292 |
| Price To Book Ratio | 1.956 | ▼-0.733 | ▼-0.404 |
| Price To Sales Ratio | 2.277 | ▼-1.036 | ▼-0.651 |
| Price To Free Cash Flow Ratio | 11.613 | ▼-21.122 | ▼-7.279 |
| Price To Operating Cash Flow Ratio | 10.937 | ▼-5.821 | ▼-4.082 |
| Debt To Assets Ratio | 0.028 | ▼-0.011 | ▼-0.015 |
| Debt To Equity Ratio | 0.042 | ▼-0.015 | ▼-0.021 |
| Debt To Capital Ratio | 0.040 | ▼-0.013 | ▼-0.019 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.470 | ▲0.049 | ▲0.013 |
| Working Capital Turnover Ratio | 18.462 | ▲6.625 | ▼-86.905 |
| Operating Cash Flow Ratio | 0.510 | ▲0.012 | ▲0.028 |
| Operating Cash Flow Sales Ratio | 0.208 | ▲0.011 | ▲0.010 |
| Free Cash Flow Operating Cash Flow Ratio | 0.942 | ▲0.430 | ▲0.081 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 4.312 | ▲1.453 | ▲1.516 |
| Capital Expenditure Coverage Ratio | 17.183 | ▲15.134 | ▼-0.750 |
| Dividend Paid And Capex Coverage Ratio | 8.540 | ▲6.713 | ▼-4.224 |
| Dividend Payout Ratio | 0.203 | ▲0.033 | ▲0.088 |
| Enterprise Value Multiple | 10.061 | ▼-3.974 | ▼-3.873 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $692.5M | $966.3M | $826.3M | $761.3M | $831.2M | |
| Enterprise value | $671.0M | $927.0M | $806.2M | $738.6M | $813.4M | |
| EV / Sales | 2.21x | 3.18x | 2.89x | 2.77x | 3.17x | |
| EV / Op. cash flow | 10.60x | 16.08x | 12.60x | 14.43x | 19.19x | |
| EV / Free cash flow | 11.25x | 31.40x | 13.05x | 14.95x | 20.87x | |
| EV / EBITDA | 10.06x | 14.04x | 13.53x | 13.80x | 18.25x | |
| Net debt / EBITDA | -0.32x | -0.59x | -0.34x | -0.42x | -0.40x | |
| Current ratio | 0.96x | 1.32x | 1.10x | 0.98x | 1.06x | |
| Income quality | 3.45x | 2.88x | 4.21x | 4.23x | 7.25x | |
| Graham number | $13 | $13 | $11 | $10 | $7 | |
| Graham net-net | -$3 | -$1 | -$2 | -$3 | -$2 | |
| Tax burden | 79.0% | 80.7% | 82.2% | 77.6% | 75.3% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | -$4.5M | $37.4M | $11.8M | -$2.8M | $6.5M | |
| Invested capital | $349.5M | $355.8M | $345.0M | $346.5M | $353.7M | |
| Return on assets | 3.5% | 3.9% | 3.0% | 2.4% | 1.2% | |
| Operating ROA | 3.9% | 4.2% | 3.2% | 2.5% | 1.6% | |
| Return on tangible assets | 9.5% | 9.1% | 7.6% | 6.5% | 3.2% | |
| Return on equity | 5.2% | 5.6% | 4.5% | 3.6% | 1.7% | |
| Return on invested capital | 4.0% | 4.3% | 3.5% | 2.5% | 1.6% | |
| Return on capital employed | 5.1% | 5.4% | 4.2% | 3.3% | 2.1% | |
| Earnings yield | 2.6% | 2.1% | 1.8% | 1.6% | 0.7% | |
| Free cash flow yield | 8.6% | 3.1% | 7.5% | 6.5% | 4.7% | |
| Capex / Op. cash flow | 5.8% | 48.8% | 3.4% | 3.5% | 8.1% | |
| Capex / Depreciation | 8.5% | 68.2% | 5.4% | 4.7% | 9.3% | |
| Capex / Sales | 1.2% | 9.6% | 0.8% | 0.7% | 1.3% | |
| SG&A / Sales | 27.0% | 28.2% | 29.2% | 30.4% | 30.8% | |
| R&D / Sales | 16.8% | 16.8% | 16.3% | 16.6% | 16.2% | |
| Stock comp / Sales | 2.7% | 1.5% | 1.5% | 1.3% | 2.1% | |
| Intangibles / Total assets | 63.0% | 56.8% | 60.0% | 62.5% | 62.5% | |
| Days sales outstanding | 47d | 44d | 50d | 58d | 50d | |
| Days payables outstanding | 26d | 25d | 29d | 29d | 21d | |
| Operating cycle | 47d | 44d | 50d | 58d | 50d | |
| Cash conversion cycle | 20d | 20d | 22d | 29d | 29d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years